Capital World Investors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.8B | Buy |
|
|||||
|
2025
Q1 | $13.8B | Buy |
|
|||||
|
2024
Q4 | $11.4B | Buy |
|
|||||
|
2024
Q3 | $12.5B | Buy |
|
|||||
|
2024
Q2 | $12.5B | Buy |
|
|||||
|
2024
Q1 | $10.7B | Buy |
|
|||||
|
2023
Q4 | $8.87B | Buy |
|
|||||
|
2023
Q3 | $6.25B | Buy |
|
|||||
|
2023
Q2 | $6.1B | Buy |
|
|||||
|
2023
Q1 | $5.09B | Buy |
|
|||||
|
2022
Q4 | $3.69B | Buy |
|
|||||
|
2022
Q3 | $3.63B | Sell |
|
|||||
|
2022
Q2 | $3.54B | Sell |
|
|||||
|
2022
Q1 | $3.31B | Buy |
|
|||||
|
2021
Q4 | $2.53B | Buy |
|
|||||
|
2021
Q3 | $2B | Buy |
|
|||||
|
2021
Q2 | $2.22B | Buy |
|
|||||
|
2021
Q1 | $2.08B | Buy |
|
|||||
|
2020
Q4 | $2.28B | Sell |
|
|||||
|
2020
Q3 | $3.09B | Sell |
|
|||||
|
2020
Q2 | $3.63B | Sell |
|
|||||
|
2020
Q1 | $2.99B | Buy |
|
|||||
|
2019
Q4 | $2.32B | Buy |
|
|||||
|
2019
Q3 | $1.79B | Sell |
|
|||||
|
2019
Q2 | $2.1B | Buy |
|
|||||
|
2019
Q1 | $2.01B | Buy |
|
|||||
|
2018
Q4 | $1.64B | Buy |
|
|||||
|
2018
Q3 | $1.48B | Sell |
|
|||||
|
2018
Q2 | $1.87B | Buy |
|
|||||
|
2018
Q1 | $1.47B | Buy |
|
|||||
|
2017
Q4 | $883M | Sell |
|
|||||
|
2017
Q3 | $1.76B | Sell |
|
|||||
|
2017
Q2 | $1.99B | Sell |
|
|||||
|
2017
Q1 | $1.96B | Sell |
|
|||||
|
2016
Q4 | $1.53B | Sell |
|
|||||
|
2016
Q3 | $1.94B | Buy |
|
|||||
|
2016
Q2 | $1.87B | Buy |
|
|||||
|
2016
Q1 | $1.72B | Buy |
|
|||||
|
2015
Q4 | $2.61B | Sell |
|
|||||
|
2015
Q3 | $2.18B | Sell |
|
|||||
|
2015
Q2 | $2.72B | Sell |
|
|||||
|
2015
Q1 | $2.77B | Sell |
|
|||||
|
2014
Q4 | $2.92B | Sell |
|
|||||
|
2014
Q3 | $2.88B | Sell |
|
|||||
|
2014
Q2 | $2.5B | Sell |
|
|||||
|
2014
Q1 | $1.89B | Buy |
|
|||||
|
2013
Q4 | $1.9B | Buy |
|
|||||
|
2013
Q3 | $1.9B | Buy |
|
|||||
|
2013
Q2 | $1.91B | Buy |
|